• Je něco špatně v tomto záznamu ?

The anti-atherosclerotic effects of puerarin on induced-atherosclerosis in rabbits

L. Bao, Y. Zhang, G. Wei, Y. Wang, R. Ma, R. Cheng, X. Ren, B. Agula,

. 2015 ; 159 (1) : 53-59. [pub] 20140127

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17006036

BACKGROUND: Cardiovascular disease is a major health issue worldwide, which has been well treated by the extracts of traditional herbs. Radix Puerariae, the dried root of the leguminous plant Pueraria lobata (Willd.) Ohwi, is a delicious vegetable in some southern provinces of China. Puerarin has also been widely used to treat human diseases, but few controlled studies are available. AIM: To determine the anti-atherosclerotic effects of puerarin on fat diet-induced atherosclerosis (AS) in rabbits. METHODS: An AS model was established by feeding 60 rabbits a high-fat diet and randomly dividing them into 6 groups: (1) normal control, (2) a model group (3) the statin, simvastatin and groups (4), (5) and (6) received 3 different amounts of puerarin. The fasting sera of all animals were collected before and after 90 days treatment to determine the levels of total cholesterol (TC), triglyceride (TG), low density lipoprotein-cholesterol (LDL-C) and high density lipoprotein-cholesterol (HDL-C). The aortas were pathomorphologically examined. PCNA and PDGF-A protein levels were assessed by Western blot. RESULTS: On the 90th day, the levels of TC, TG and LDL-C were significantly lower in high- and middle-dose puerarin groups and simvastatin group than in the model group (P<0.05), and the HDL-C level was higher. The percentages of plaque area to the total aortic area differed significantly for high- and middle-dose puerarin groups, simvastatin group and model group (P<0.05). Whole blood viscosity increased in the high-fat diet groups, while those in the treatment groups (except for the low-dose puerarin group) were significantly lower than those in the model group (P<0.05). PCNA and PDGF-A protein expression levels of rabbit aorta were low in the normal group. Protein expression levels in the groups fed the high-fat diet were significantly increased (P<0.05), but those in the high-dose puerarin group and simvastatin group were significantly decreased compared with the model group (P<0.05). CONCLUSIONS: Puerarin inhibits the formation and development of AS plaque and suppresses the migration and reproduction of vascular smooth muscle cells by decreasing PCNA and PDGF-A expressions in the rabbit. This is encouraging in terms of cardiovascular disease prevention/treatment.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17006036
003      
CZ-PrNML
005      
20170308085059.0
007      
ta
008      
170210s2015 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2013.096 $2 doi
035    __
$a (PubMed)24510110
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Bao, Lidao $u Department of Pharmacy, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, P. R. China
245    14
$a The anti-atherosclerotic effects of puerarin on induced-atherosclerosis in rabbits / $c L. Bao, Y. Zhang, G. Wei, Y. Wang, R. Ma, R. Cheng, X. Ren, B. Agula,
520    9_
$a BACKGROUND: Cardiovascular disease is a major health issue worldwide, which has been well treated by the extracts of traditional herbs. Radix Puerariae, the dried root of the leguminous plant Pueraria lobata (Willd.) Ohwi, is a delicious vegetable in some southern provinces of China. Puerarin has also been widely used to treat human diseases, but few controlled studies are available. AIM: To determine the anti-atherosclerotic effects of puerarin on fat diet-induced atherosclerosis (AS) in rabbits. METHODS: An AS model was established by feeding 60 rabbits a high-fat diet and randomly dividing them into 6 groups: (1) normal control, (2) a model group (3) the statin, simvastatin and groups (4), (5) and (6) received 3 different amounts of puerarin. The fasting sera of all animals were collected before and after 90 days treatment to determine the levels of total cholesterol (TC), triglyceride (TG), low density lipoprotein-cholesterol (LDL-C) and high density lipoprotein-cholesterol (HDL-C). The aortas were pathomorphologically examined. PCNA and PDGF-A protein levels were assessed by Western blot. RESULTS: On the 90th day, the levels of TC, TG and LDL-C were significantly lower in high- and middle-dose puerarin groups and simvastatin group than in the model group (P<0.05), and the HDL-C level was higher. The percentages of plaque area to the total aortic area differed significantly for high- and middle-dose puerarin groups, simvastatin group and model group (P<0.05). Whole blood viscosity increased in the high-fat diet groups, while those in the treatment groups (except for the low-dose puerarin group) were significantly lower than those in the model group (P<0.05). PCNA and PDGF-A protein expression levels of rabbit aorta were low in the normal group. Protein expression levels in the groups fed the high-fat diet were significantly increased (P<0.05), but those in the high-dose puerarin group and simvastatin group were significantly decreased compared with the model group (P<0.05). CONCLUSIONS: Puerarin inhibits the formation and development of AS plaque and suppresses the migration and reproduction of vascular smooth muscle cells by decreasing PCNA and PDGF-A expressions in the rabbit. This is encouraging in terms of cardiovascular disease prevention/treatment.
650    _2
$a zvířata $7 D000818
650    _2
$a ateroskleróza $x krev $x farmakoterapie $7 D050197
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a isoflavony $x terapeutické užití $7 D007529
650    _2
$a lipidy $x krev $7 D008055
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a králíci $7 D011817
650    _2
$a vazodilatancia $x terapeutické užití $7 D014665
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Zhang, Ying $u Department of Respiratory Medicine, Binzhou People's Hospital, Binzhou, P. R. China
700    1_
$a Wei, Guomin $u Department of Respiratory Medicine, Binzhou People's Hospital, Binzhou, P. R. China
700    1_
$a Wang, Yi $u Department of Pharmacy, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, P. R. China
700    1_
$a Ma, Ruilian $u Department of Pharmacy, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, P. R. China
700    1_
$a Cheng, Rui $u Department of Pharmacy, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, P. R. China
700    1_
$a Ren, Xianhua $u Department of Pharmacy, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, P. R. China
700    1_
$a Agula, B $u College of Traditional Mongolia Medicine, Inner Mongolia Medical University, Hohhot, P. R. China $7 gn_A_00002334
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 159, č. 1 (2015), s. 53-59
856    41
$u http://biomed.papers.upol.cz/ $y domovská stránka časopisu
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20170210 $b ABA008
991    __
$a 20170223131440 $b ABA008
999    __
$a ok $b bmc $g 1192566 $s 966683
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 159 $c 1 $d 53-59 $e 20140127 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20170210

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace